|
|
Post by agedhippie on Nov 23, 2019 19:26:52 GMT -5
This makes no difference to at all to HfM. They were going to have to take seats away from the current directors last week and that is still the case. If HfM have the shares then it will happen - that's the nature of a proxy slate. As to the idea that pharma experience is necessary to be a board member, well that would rule out Kent Kresa and Ronald Consiglio. Right now what is needed on the board is business ability, not pharma experience. We have the board we do because Al wanted a passive board so he could run the show, and he had the shares to make it so. Unfortunately Al is no longer here but the supine board still largely is. The board should be holding the executives' feet to the fire and demanding measurable deliverables, not approving new bonuses because management missed their targets and wouldn't otherwise get a bonus. All Boards are crafted by the CEO and have a tilt towards their Ideas & Plans. Mike will eventually get his guys in there. And I'm sure the way Bill & VDEX are acting HE WILL NOT BE SELECTED. That is absolutely not the case. The board is there to represent the shareholders interest and having the board crafted by the CEO is a compliance red flag. There is a reason the independent board directors are called that. If the board is allowing that to happen (boards can be negligent) then they are putting themselves at risk. If the shareholders select Bill (VDEX is a company and companies cannot be board members on public companies) then there is absolutely nothing Mike or any other director can do about it. The board is in the gift of the shareholders, not Mike. If that wasn't the case hostile takeovers would be impossible. |
|
|
|
Post by lifebreath on Nov 23, 2019 19:35:06 GMT -5
All Boards are crafted by the CEO and have a tilt towards their Ideas & Plans. Mike will eventually get his guys in there. And I'm sure the way Bill & VDEX are acting HE WILL NOT BE SELECTED. That is absolutely not the case. The board is there to represent the shareholders interest and having the board crafted by the CEO is a compliance red flag. There is a reason the independent board directors are called that. If the board is allowing that to happen (boards can be negligent) then they are putting themselves at risk. If the shareholders select Bill (VDEX is a company and companies cannot be board members on public companies) then there is absolutely nothing Mike or any other director can do about it. The board is in the gift of the shareholders, not Mike. If that wasn't the case hostile takeovers would be impossible. I was wondering if anyone was going to call him out on that ridiculous post. |
|
|
|
Post by sportsrancho on Nov 23, 2019 20:36:10 GMT -5
|
|
|
|
Post by ktim on Nov 23, 2019 20:45:32 GMT -5
Just curious how you reason. In general things that are expected and happen don't effect stock price that greatly. In my mind the pediatric trial, while taking longer to get started than almost anyone wanted, is a known quantity since I don't believe anyone has any real doubts that Afrezza will work in children just as well as it does in adults as every other form of insulin has. What's your reason for thinking that would cause a 50% jump in share price... are you thinking there is some risk that ped trial will have bad outcome and thus good outcome will surprise? I know some believe a new adjective is a big deal despite the pk/pd already clearly being in prescribing lit, so on that one I'll just assume you're very very pro adjective. On the "secret molecule", TreT has not contributed anywhere close to $1.50 to share price. You think the new molecule will have more promise than TreT? Pediatric approval is the holy grail for Afrezza. Parents don't like using needles on their kids and Afrezza is much more forgiving than RAAs. Oh there are doubts especially with MNKD. Nothing is certain. The stock will start climbing and the PR will let Wall Street know approval is in process. Right now PEDS Filing or Approval is not factored in the stock price. The SHORTS are keeping the price depressed so once a PR is release about the PEDS it will change things. The New Classification is bigger than the PEDS Trial. You're talking about No Restrictions when it comes to Afrezza. This is a long haul to change but if they can it will be a game changer. Also the FDA will probably add Fiasp in the ULTRA Group. They generally don't like having one drug all by itself. It'll be up to Kendall to get it done. I'm also hoping Kendall and Mike are working on getting the BLACK BOX warning remove or LESSEN. Yes but that's not my thinking. MNKD will get more money (~$35M) for the new molecule and if you add the growing Afrezza sales and add'l $25M in milestones for TreT it will give Wall Street a better comfort level in MNKD's Balance Sheet. That will cause the stock price to rise. OMG... you mentioned MNKD PR... fell off my chair laughing... that's a good one  [sorry, sarcasm off now] Clinical trials are under way for peds... but you think that's going to catch investors by surprise when it finishes? Guess I don't buy that. I think there will be some gradual positive pressure on stock over the still rather lengthy approval process for peds. You are right that it isn't fully valued in, but I don't believe it's an issue of having some one time event, it's simply the discount factor applied due to how far out the ultimate approval will be. And time will tell if ped endos are more receptive to Afrezza. True there is the needle thing, but there is also the likely unfounded concern expressed by some in medical community over the long term lung safety... doctors that have that concern likely to have it even more with regard to still developing bodies. I doubt Wall Street will have the level of faith in peds being a game changer that many long term MNKD shareholders believe, though peds is unarguably additional potential patients. As for the classification if you're talking about prior auths and tiers with insurance I think you're simply indulging in some fantasy. The FDA allowing them to call it by a different classification doesn't mean insurers have to treat it any differently. There are certain classes of drugs, including ones for diabetes, where all of the "class members" have restrictions and worse tier placement than other preferred drugs that may be a different class but treat the same disorder/disease. If you have some reference indicating this "no restriction" is true, please do let me know. I know that has been tossed around on this forum, but to my knowledge that has no real basis. One can still have hope that importance of post prandial excursions and TIR become generally accepted and that eventually ADA acknowledges role of faster pk/pd prandial in achieving outcomes... then it becomes much harder for insurers to put up barriers, but that's going to take trials and time. I agree with you that the extra cash from having UTHR pick up the second API will boost share price a bit, but nowhere near $1.50/sh. The market cap is unlikely to go up by 10x the amount of cash received. And of course whether it's boosting price from where we are now if that happens soon or whether it is a share price boost from a lower level if it is delayed much more is something I'd question. Fingers crossed it happens before it appears that extra tranches from lender likely to not happen. |
|
|
|
Post by audiomr on Nov 23, 2019 23:59:56 GMT -5
As soon as interim trial results start coming out of either India or U.S. pediatric trials, whichever comes first. Sanofi dropped us saying the product didn't work. We need to disprove that failure in the eyes of WS. There is always the chance of another UT like partnership announcement. (jumped over $6 last time, which probably more closely reflects the true stock price when shorts start to exit en mass)JMHO Sanofi didn't say the product didn't work -- just that it didn't sell. Revenue is up more than 60% from last year at this time. If that trend continues, we'll be okay. |
|
|
|
Post by radgray68 on Nov 24, 2019 14:04:32 GMT -5
As soon as interim trial results start coming out of either India or U.S. pediatric trials, whichever comes first. Sanofi dropped us saying the product didn't work. We need to disprove that failure in the eyes of WS. There is always the chance of another UT like partnership announcement. (jumped over $6 last time, which probably more closely reflects the true stock price when shorts start to exit en mass)JMHO Sanofi didn't say the product didn't work -- just that it didn't sell. Revenue is up more than 60% from last year at this time. If that trend continues, we'll be okay. Yes, as I recall, they did indicate that it didn't work as well as advertised. That wasn't in the press release, I don't believe, but the sales reps were saying it. I remember how badly it hurt to hear at the time. We now know that Afrezza was not being dosed properly. Underdosing has now been addressed, but the stain remained. The trend will get us solvent, but the change in protocol of the future trials, and the results they show in a meaningfully sized trial group, are going to reawaken the awareness of diabetics and Wall Street big time. Interim results, mark your calendars. |
|
|
|
Post by ktim on Nov 24, 2019 14:41:35 GMT -5
As soon as interim trial results start coming out of either India or U.S. pediatric trials, whichever comes first. Sanofi dropped us saying the product didn't work. We need to disprove that failure in the eyes of WS. There is always the chance of another UT like partnership announcement. (jumped over $6 last time, which probably more closely reflects the true stock price when shorts start to exit en mass)JMHO Sanofi didn't say the product didn't work -- just that it didn't sell. Revenue is up more than 60% from last year at this time. If that trend continues, we'll be okay. There is a trend that is continuing, but it is linear growth, so that 60% you cite doesn't represent the trend. In percentage terms it is dropping year by year. Check out the nice graphs Earl Grey posts here to see the actual trend... some noise but overall it's a straight line, for better or worse. |
|
|
|
Post by rockstarrick on Nov 24, 2019 15:24:06 GMT -5
Sanofi didn't say the product didn't work -- just that it didn't sell. Revenue is up more than 60% from last year at this time. If that trend continues, we'll be okay. Yes, as I recall, they did indicate that it didn't work as well as advertised. That wasn't in the press release, I don't believe, but the sales reps were saying it. I remember how badly it hurt to hear at the time. We now know that Afrezza was not being dosed properly. Underdosing has now been addressed, but the stain remained. The trend will get us solvent, but the change in protocol of the future trials, and the results they show in a meaningfully sized trial group, are going to reawaken the awareness of diabetics and Wall Street big time. Interim results, mark your calendars. If my memory serves me right, there were Healthcare Providers telling people with diabetes that Afrezza was being discontinued, and this type of horseplay continued well after MNKD regained all rights to Afrezza. Sanofi and some of their sales representatives were definitely doing their very best to stack the deck against Afrezza and MNKD. I’m quite sure this information wasn’t coming from anybody at MNKD. Not to mention PWD from Canada were constantly tweeting Sanofi Canada to try and find out when Afrezza would be available in Canada, and Sanofi Canada basically lied to them right up to the day Sanofi announced they were dropping Afrezza. They would’ve been better off just not answering the tweets, but instead just fed everybody that asked a big line of crap. 2014, and 2015 were 2 years that destroyed my faith in our Healthcare System. Not only due to the Sanofi fiasco, but also due to complacency by my own PCP. In May 2014, I was rear ended at work by a distracted driver, while I was stopped waiting for a School bus to drop a load of kids. In the accident, both vehicles were completely totaled, the stainless steel bars on my headrest were bent nearly 45 degrees by my head, the drivers seat was completely broken loose from the frame of the car, and the steering wheel was bent over 6 inches in towards me on both sides, where my hands had a death grip on it as I braced for impact. Anyway, with absolutely zero diagnostic tests, my PCP prescribed Physical Therapy. The more I went, the worse I got, so I told him I wasn’t responding well to the PT, he responded by telling me that he was leaving on vacation, and when he got back he was releasing me back to work. That’s what he did, I worked 1 day and couldn’t get out of bed the next. After consulting with both my Employer and my PCP about my condition, my PCP signed a notarized statement claiming that it was his professional opinion that there was nothing wrong with me and I could return to full duty. I immediately consulted with my attorney, and scheduled an MRI. Within a week of getting the results I was in emergency surgery getting a complete disc replacement @ C6. Several other tests, (MRI’s, EMG’s), revealed that my left bicep had detached, my left rotator cuff was blown in 2 places, and I had severe nerve damage all through my left arm, hand, and fingers from the spinal cord damage @ C6. What happened next was one of the most incredible things that I have ever been a part of in my 58 years. After hearing of all the Injuries I sustained in the accident that my PCP failed to diagnose, Instead of apologizing, my PCP kicked my entire family out of the clinic. We had been going there since 1986, with double coverage. The Saga Continues 😎 |
|
|
|
Post by mytakeonit on Nov 24, 2019 15:42:57 GMT -5
rockstar - Is that when you started to collect guns? Sounds like something I might have done.
But, that's mytakeonit
|
|
|
|
Post by rockstarrick on Nov 24, 2019 19:05:55 GMT -5
rockstar - Is that when you started to collect guns? Sounds like something I might have done. But, that's mytakeonit No, I was raised in a small town in Northwest Montana, the Guns were for protection from man eaters, and in case I saw a deer on the way to school. My Father spent many years in Law Enforcement in Washington State, so regardless if I was with my Mother in Montana, or my Father in Washington, Guns were always in the House. ✌🏻😎 |
|
|
|
Post by bones1026 on Nov 24, 2019 22:35:08 GMT -5
If I may simplify, rather than get into detailed scenarios, Wall Street generally values most stock based upon actual (current) results in combination with its understanding of whether short- and near-term events will affect a company’s revenue. In a nutshell, MNKD is valued where it is today because Wall Street doesn’t see any pivotal events on short/near-term horizon. Frankly, management has only itself to blame for the poor (or lack of) company image and the continued erosion of share price (aka shareholder value). The closest known events are the TreT clinical trial and the Afrezza Phase 3 pediatric trial and that’s not near-term by any means. Everything else is entirely speculative because this company does a poor job of communicating its potential to the public. Wall Street will continue to under value this stock until that changes. Would agree if not for the 70% short volume going on daily..big money can pin in wherever they want for now..that does come with tremendous risk..but they have been right so... as management hasn’t delivered the type of news/sales to to make them panic |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 24, 2019 23:08:44 GMT -5
Yes, as I recall, they did indicate that it didn't work as well as advertised. That wasn't in the press release, I don't believe, but the sales reps were saying it. I remember how badly it hurt to hear at the time. We now know that Afrezza was not being dosed properly. Underdosing has now been addressed, but the stain remained. The trend will get us solvent, but the change in protocol of the future trials, and the results they show in a meaningfully sized trial group, are going to reawaken the awareness of diabetics and Wall Street big time. Interim results, mark your calendars. If my memory serves me right, there were Healthcare Providers telling people with diabetes that Afrezza was being discontinued, and this type of horseplay continued well after MNKD regained all rights to Afrezza. Sanofi and some of their sales representatives were definitely doing their very best to stack the deck against Afrezza and MNKD. I’m quite sure this information wasn’t coming from anybody at MNKD. Not to mention PWD from Canada were constantly tweeting Sanofi Canada to try and find out when Afrezza would be available in Canada, and Sanofi Canada basically lied to them right up to the day Sanofi announced they were dropping Afrezza. They would’ve been better off just not answering the tweets, but instead just fed everybody that asked a big line of crap. 2014, and 2015 were 2 years that destroyed my faith in our Healthcare System. Not only due to the Sanofi fiasco, but also due to complacency by my own PCP. In May 2014, I was rear ended at work by a distracted driver, while I was stopped waiting for a School bus to drop a load of kids. In the accident, both vehicles were completely totaled, the stainless steel bars on my headrest were bent nearly 45 degrees by my head, the drivers seat was completely broken loose from the frame of the car, and the steering wheel was bent over 6 inches in towards me on both sides, where my hands had a death grip on it as I braced for impact. Anyway, with absolutely zero diagnostic tests, my PCP prescribed Physical Therapy. The more I went, the worse I got, so I told him I wasn’t responding well to the PT, he responded by telling me that he was leaving on vacation, and when he got back he was releasing me back to work. That’s what he did, I worked 1 day and couldn’t get out of bed the next. After consulting with both my Employer and my PCP about my condition, my PCP signed a notarized statement claiming that it was his professional opinion that there was nothing wrong with me and I could return to full duty. I immediately consulted with my attorney, and scheduled an MRI. Within a week of getting the results I was in emergency surgery getting a complete disc replacement @ C6. Several other tests, (MRI’s, EMG’s), revealed that my left bicep had detached, my left rotator cuff was blown in 2 places, and I had severe nerve damage all through my left arm, hand, and fingers from the spinal cord damage @ C6. What happened next was one of the most incredible things that I have ever been a part of in my 58 years. After hearing of all the Injuries I sustained in the accident that my PCP failed to diagnose, Instead of apologizing, my PCP kicked my entire family out of the clinic. We had been going there since 1986, with double coverage. The Saga Continues 😎 That makes no sense. Why didn't you go to the hospital? I'm sure the ER would have done an MRI and given you the proper treatment. Why you would rely on your Primary Care Doctor? Why didn't you go see a spine and neck specialist?? |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 24, 2019 23:13:50 GMT -5
That is absolutely not the case. The board is there to represent the shareholders interest and having the board crafted by the CEO is a compliance red flag. There is a reason the independent board directors are called that. If the board is allowing that to happen (boards can be negligent) then they are putting themselves at risk. If the shareholders select Bill (VDEX is a company and companies cannot be board members on public companies) then there is absolutely nothing Mike or any other director can do about it. The board is in the gift of the shareholders, not Mike. If that wasn't the case hostile takeovers would be impossible. I was wondering if anyone was going to call him out on that ridiculous post. You can believe whatever you want. |
|
|
|
Post by rockstarrick on Nov 24, 2019 23:38:18 GMT -5
If my memory serves me right, there were Healthcare Providers telling people with diabetes that Afrezza was being discontinued, and this type of horseplay continued well after MNKD regained all rights to Afrezza. Sanofi and some of their sales representatives were definitely doing their very best to stack the deck against Afrezza and MNKD. I’m quite sure this information wasn’t coming from anybody at MNKD. Not to mention PWD from Canada were constantly tweeting Sanofi Canada to try and find out when Afrezza would be available in Canada, and Sanofi Canada basically lied to them right up to the day Sanofi announced they were dropping Afrezza. They would’ve been better off just not answering the tweets, but instead just fed everybody that asked a big line of crap. 2014, and 2015 were 2 years that destroyed my faith in our Healthcare System. Not only due to the Sanofi fiasco, but also due to complacency by my own PCP. In May 2014, I was rear ended at work by a distracted driver, while I was stopped waiting for a School bus to drop a load of kids. In the accident, both vehicles were completely totaled, the stainless steel bars on my headrest were bent nearly 45 degrees by my head, the drivers seat was completely broken loose from the frame of the car, and the steering wheel was bent over 6 inches in towards me on both sides, where my hands had a death grip on it as I braced for impact. Anyway, with absolutely zero diagnostic tests, my PCP prescribed Physical Therapy. The more I went, the worse I got, so I told him I wasn’t responding well to the PT, he responded by telling me that he was leaving on vacation, and when he got back he was releasing me back to work. That’s what he did, I worked 1 day and couldn’t get out of bed the next. After consulting with both my Employer and my PCP about my condition, my PCP signed a notarized statement claiming that it was his professional opinion that there was nothing wrong with me and I could return to full duty. I immediately consulted with my attorney, and scheduled an MRI. Within a week of getting the results I was in emergency surgery getting a complete disc replacement @ C6. Several other tests, (MRI’s, EMG’s), revealed that my left bicep had detached, my left rotator cuff was blown in 2 places, and I had severe nerve damage all through my left arm, hand, and fingers from the spinal cord damage @ C6. What happened next was one of the most incredible things that I have ever been a part of in my 58 years. After hearing of all the Injuries I sustained in the accident that my PCP failed to diagnose, Instead of apologizing, my PCP kicked my entire family out of the clinic. We had been going there since 1986, with double coverage. The Saga Continues 😎 That makes no sense. Why didn't you go to the hospital? I'm sure the ER would have done an MRI and given you the proper treatment. Why you would rely on your Primary Care Doctor? Why didn't you go see a spine and neck specialist?? I was rushed to the hospital by ambulance, they did a cat scan, no MRI. And you’re right, it makes no sense, but it happened, and it’s not over yet. The notarized statements to my employer without any diagnostics probably saved me from being a quadriplegic, because it forced me to get the opinion of a Specialist, who immediately ordered the MRI that saved my butt. I’ve now had 7 since 2014. |
|
|
|
Post by sportsrancho on Nov 25, 2019 9:52:35 GMT -5
They don’t do MRIs when you get rushed to the hospital, I know that for a fact, you have to get a referral for an MRI. All you get at the hospital is an x-ray. Which most of the time tells you jack nothing.
|
|
[sorry, sarcasm off now]
